Kivlighn, S D <br/><br/>
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.  [electronic resource] 

 -  American journal of hypertension  Jan 1995 
 - 58-66 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0895-7061 
<br/><br/><label>Standard No.: </label>10.1016/0895-7061(94)00169-c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aldosterone--blood<br/>Angiotensin II--antagonists & inhibitors<br/>Angiotensin Receptor Antagonists<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Biphenyl Compounds--pharmacology<br/>Bradykinin--pharmacology<br/>Dogs<br/>Enalapril--pharmacology<br/>Female<br/>Imidazoles--pharmacology<br/>Injections, Intravenous<br/>Losartan<br/>Macaca mulatta<br/>Male<br/>Nitroglycerin--pharmacology<br/>Pan troglodytes<br/>Pyridines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tetrazoles--pharmacology